{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:44:06Z","timestamp":1792619046581,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019472","name":"Stichting Kwaliteitsgelden Medisch Specialisten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.esmoop.2022.100775","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T12:10:52Z","timestamp":1673871052000},"page":"100775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure"],"prefix":"10.1016","volume":"8","author":[{"given":"E.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Pos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"de Feijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hulshof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Budiharto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"de Ligt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2022.100775_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100775_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100775_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ejca.2010.03.040","article-title":"Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006","volume":"46","author":"Cremers","year":"2010","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.esmoop.2022.100775_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100775_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.eururo.2017.06.035","article-title":"Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review","volume":"72","author":"Lardas","year":"2017","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100775_bib7","first-page":"530","article-title":"Agreement between patient-reported symptoms and their documentation in the medical record","volume":"14","author":"Pakhomov","year":"2008","journal-title":"Am J Manag Care"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100775_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.esmoop.2022.100775_bib9","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","article-title":"How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30","volume":"22","author":"Fromme","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100775_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11136-011-0031-4","article-title":"Reliability of adverse symptom event reporting by clinicians","volume":"21","author":"Atkinson","year":"2012","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100775_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100775_bib12","doi-asserted-by":"crossref","first-page":"dju244","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100775_bib13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-15-2035","article-title":"Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms","volume":"22","author":"Kluetz","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2022.100775_bib14","series-title":"EORTC QUALITY OF LIFE GROUP Guidelines for Developing Questionnaire Modules","author":"Johnson","year":"2011"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100775_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2648.2006.03716.x","article-title":"Consulting the oracle: ten lessons from using the Delphi technique in nursing research","volume":"53","author":"Keeney","year":"2006","journal-title":"J\u00a0Adv Nurs"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100775_bib16","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2215\/CJN.03780320","article-title":"A\u00a0RAND-modified delphi on\u00a0key indicators to measure the efficiency of living kidney donor\u00a0candidate evaluations","volume":"15","author":"Habbous","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100775_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100775_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/ciz362","article-title":"Quality indicators for appropriate outpatient parenteral antimicrobial therapy in adults: a systematic review and RAND-modified Delphi procedure","volume":"70","author":"Berrevoets","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100775_bib19","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1007\/s00464-016-4931-9","article-title":"A\u00a0modified Delphi method toward multidisciplinary consensus on functional convalescence recommendations after abdominal surgery","volume":"30","author":"van Vliet","year":"2016","journal-title":"Surg Endosc"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100775_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bju.13499","article-title":"Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review","volume":"118","author":"Whiting","year":"2016","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100775_bib21","doi-asserted-by":"crossref","first-page":"dju132","DOI":"10.1093\/jnci\/dju132","article-title":"Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials","volume":"106","author":"Chen","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100775_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin Trials"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100775_bib23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.eururo.2015.06.007","article-title":"Development of a standardized set of patient-centered outcomes for advanced prostate cancer: an international effort for a unified approach","volume":"68","author":"Morgans","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100775_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.eururo.2014.08.075","article-title":"Defining a standard set of patient-centered outcomes for men with localized prostate cancer","volume":"67","author":"Martin","year":"2015","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100775_bib25","first-page":"383","article-title":"The role of health literacy in patient-physician communication","volume":"34","author":"Williams","year":"2002","journal-title":"Fam Med"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100775_bib26","first-page":"493","article-title":"A\u00a0life course approach to health literacy: the role of gender, educational attainment and lifetime cognitive capability","volume":"46","author":"Clouston","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.esmoop.2022.100775_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2018.11.023","article-title":"Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core","volume":"107","author":"Liegl","year":"2019","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100775_bib28","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: Cancer J Clin"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922004094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922004094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:31:06Z","timestamp":1761856266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922004094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2059702922004094"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100775","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100775"}}